(Q46494159)

English

Efficacy of a continuous venous infusion of fluorouracil and daily divided dose cisplatin as adjuvant therapy in resectable colorectal cancer: a prospective randomized trial

scientific article published on 9 July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

Efficacy of a continuous venous infusion of fluorouracil and daily divided dose cisplatin as adjuvant therapy in resectable colorectal cancer: a prospective randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Fumitake Hata

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

Kazuaki Sasaki

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

Koichi Hirata

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

Susumu Yamamitsu

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

Tetsuhiko Shirasaka

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

publication date

9 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

38

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

623-632

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

[Cooperative Study of Surgical Adjuvant Chemotherapy for Colorectal Cancer (third report): five-year results after surgery]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin and infusional cytosine arabinoside for the treatment of colorectal adenocarcinoma: a phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized trial of continuous infusion 5-fluorouracil (5-FU) versus 5-FU plus cisplatin in patients with advanced colorectal cancer. A trial of the Spanish Cooperative Group for Digestive Tract Tumor Therapy (T.T.D.)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: report from the Japan Clinical Oncology Group (JCOG).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy of 5-fluorouracil and low-dose cisplatin in advanced and recurrent gastric cancer: a multicenter retrospective study in Nagasaki, Japan.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Current status of low-dose CDDP. 5-FU therapy for solid malignant tumors--nationwide questionnaire survey]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methionine starvation modulates the efficacy of cisplatin on human breast cancer in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protracted infusion of 5-FU with weekly low-dose cisplatin as second-line therapy in patients with metastatic colorectal cancer who have failed 5-FU monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and patterns of recurrence following curative resection for colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Study of serum CDDP concentrations in patients with advanced or recurrent adeno-or squamous cell carcinoma under combination chemotherapy of 5-FU (CIV) and low-dose CDDP (IV)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination phase I trial of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU Study Group--third study on colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18612787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00595-007-3689-Z

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18612787

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46494159&oldid=2113714631"